FEBUTEC 40

Description

Febutec 40 Tablet is a medicine manufactured by Cipla Ltd, containing Febuxostat (40mg) as its active ingredient. It is primarily prescribed for the management of gout and conditions associated with elevated uric acid levels (hyperuricemia).

How it Works:
Febuxostat is a xanthine oxidase inhibitor. It works by selectively blocking the enzyme xanthine oxidase, which is responsible for the production of uric acid in the body. By lowering uric acid levels, Febutec 40 helps to prevent the formation of urate crystals in the joints, tissues, and kidneys. This action reduces the risk of gout attacks, joint pain, swelling, and kidney stone formation.

Uses of Febutec 40:

• Long-term management of gout

• Treatment of chronic hyperuricemia

• Prevention of gouty arthritis flare-ups

• Reduces the risk of uric acid kidney stones

Key Benefits:

• Effectively lowers and maintains healthy uric acid levels

• Prevents recurrent and painful gout attacks

• Protects joints from damage and inflammation

• Reduces the risk of complications related to chronic gout

Dosage & Administration:

• Generally prescribed as one tablet daily, with or without food, or as directed by a physician.

• Adequate hydration is recommended to support kidney function and reduce uric acid buildup.

• Dose adjustments may be necessary based on serum uric acid levels and patient response.

Safety & Precautions:

• Should be used under medical supervision.

• Inform your doctor if you have a history of liver disease, kidney problems, or heart disease.

• Regular monitoring of uric acid levels, liver function, and kidney function may be required during treatment.

• May cause side effects like nausea, headache, diarrhea, joint pain, or rash in some individuals.

• Not recommended during pregnancy and breastfeeding unless prescribed.

• Avoid alcohol and purine-rich foods (like red meat, seafood, and organ meats) as they can worsen gout.